Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 513 results found. Search for [ cadila ]

Results 1 to 21 of 513
PTI
August 13, 2020
The drug discovery pipeline is a type of computational strategy linked to AI -- a computer algorithm that learns to predict activity through trial and error, improving over time


PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical


Reuters
August 13, 2020
Zydus has priced it at 2,800 rupees ($37.44) per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients


BusinessToday.In
August 12, 2020
The committee members will take the decision on vaccines that will be effective for Indian citizens. The task force will also chalk out a budget and discuss how capital can be raised for procurement, distribution of the vaccine


BusinessToday.In
August 8, 2020
The task force will also chalk out a budget and discuss how capital can be raised for procurement, distribution of the vaccine


BusinessToday.In
August 8, 2020
Coronavirus vaccine update: Serum Institute of India might begin its Phase 2 and 3 clinical trials in India within a week. Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate are going on in the United Kingdom, phase 3 clinical trial in Brazil


BusinessToday.In
August 7, 2020
The vaccine formulated by the Gamaleya Institute is currently undergoing clinical trials at two sites -- Burdenko Main Military Clinical Hospital and the Sechenov First Moscow State Medical University


BusinessToday.In
August 7, 2020
Lupin stock declined 6.55% to  Rs 874.9 against previous close of Rs 936.25 on BSE


BusinessToday.In
August 7, 2020
Coronavirus vaccine news update: Serum Institute of India would have exclusive rights for the supply of the Novavax COVID-19 vaccine in India


PB Jayakumar
August 6, 2020
Though margins remain healthy, pricing pressures for the US base generics business, lack of limited competition products and manufacturing quality issues will continue to trouble them, said ICRA


BusinessToday.In
August 6, 2020
Following the result update, Cadila Healthcare shares fell 1.57% to the intraday low of Rs 389.55 on BSE against the earlier close of Rs 395.95. The stock also hit an intraday high of Rs 401.80 during today's session, after opening at Rs 396


Reuters
August 6, 2020
Last week, Moderna announced the start of a late-stage trial on 30,000 people to demonstrate that its vaccine is safe and effective, the final hurdle prior to regulatory approval


BusinessToday.In
August 6, 2020
India Stock Market Highlights Today: ONGC, followed by Tech Mahindra, TCS, HCL Tech, NTPC, Infosys and HDFC duo were among the top gainers today, while Maruti, Axis Bank, Bharti Airtel, M&M and Reliance Industries were among the laggards.


Rupa Burman Roy
August 5, 2020
Today's volatile trade in the domestic equity market was despite strong global equities that trade bullish on hopes of US-China trade talks meet scheduled on August 15 and on the progress in the economic aid package in the US


Reuters
August 5, 2020
\"The study is designed to support the regulatory approval process for the Chinese market and intends to confirm that the safety and immunogenicity profile observed in participants from the German and US trials is comparable to that of Chinese participants,\" BioNTech said in a statement


PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila


BusinessToday.In
August 5, 2020
Coronavirus vaccine news update: The Phase II trial will evaluate the humoral and cellular immune response for the coronavirus vaccine candidate, keeping in line with the current global protocols


Rupa Burman Roy
August 5, 2020
Gold price today: Supported by upbeat safe-haven demand, Gold August futures on Multi Commodity Exchange were trading higher by Rs 513 to Rs 55,064 per 10 gm against the previous close of Rs 54,551 per 10 gm, after touching an intraday high as well as an all-time high of Rs 55,200 today


BusinessToday.In
August 5, 2020
India Stock Market Highlights Today: Global equities were buoyed today as positive macroeconomic data flow and hopes of a COVID-19 vaccine boosted investor sentiment.


BusinessToday.In
August 5, 2020
Stocks to watch today on August 5: Axis Bank, Tata Consumer, Unichem Labs, HPCL, Havells India among others are the top stocks to watch out for in Wednesday's trading session


PAGES 1 OF 26  12345